SRC and chronic myelogenous leukemia, BCR-ABL1 positive: Src is also thought to have a role in the progression of CML, AML, CLL, and ALL through activation of STAT pathways and regulation of RAS/RAF/MEK/ERK MAPK and VEGF pathways.